Enlitic
Total Raised
$55MInvestors Count
10Deal Terms
2Funding, Valuation & Revenue
6 Fundings
Enlitic has raised $55M over 6 rounds.
Enlitic's latest funding round was a Series B - II for $25M on November 14, 2019.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/14/2019 | Series B - II | $25M | 5 | |||
1/7/2019 | Series B | |||||
10/27/2015 | Series A | |||||
2/1/2015 | Seed VC - II | |||||
10/29/2014 | Seed VC |
Date | 11/14/2019 | 1/7/2019 | 10/27/2015 | 2/1/2015 | 10/29/2014 |
|---|---|---|---|---|---|
Round | Series B - II | Series B | Series A | Seed VC - II | Seed VC |
Amount | $25M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 5 |
Enlitic Deal Terms
2 Deal Terms
Enlitic's deal structure is available for 2 funding rounds, including their Series A from October 27, 2015.
Round | Series A | Seed VC - II |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A | |||||||||||||||
Seed VC - II |
Enlitic Investors
10 Investors
Enlitic has 10 investors. Amplify Partners invested in Enlitic's Series B - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/29/2014 | 11/14/2019 | 3 Seed VC, Seed VC - II (2015), Series B - II (2019) | Venture Capital | California | ||
10/27/2015 | 11/14/2019 | 3 Series A, Series B (2019), Series B - II (2019) | Venture Capital | New York | ||
1/7/2019 | 11/14/2019 | 2 Series B, Series B - II (2019) | Corporation | Japan | ||
Asset/Investment Management | Australia | |||||
Family Office |
First funding | 10/29/2014 | 10/27/2015 | 1/7/2019 | ||
|---|---|---|---|---|---|
Last Funding | 11/14/2019 | 11/14/2019 | 11/14/2019 | ||
Investor | |||||
Rounds | 3 Seed VC, Seed VC - II (2015), Series B - II (2019) | 3 Series A, Series B (2019), Series B - II (2019) | 2 Series B, Series B - II (2019) | ||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Corporation | Asset/Investment Management | Family Office |
Location | California | New York | Japan | Australia |
Enlitic Acquisitions
1 Acquisition
Enlitic acquired 1 company. Their latest acquisition was Laitek on August 29, 2024.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/29/2024 | Acquired | 2 |
Date | 8/29/2024 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 2 |
Compare Enlitic to Competitors
Claritas HealthTech develops image enhancement and AI-assisted diagnostic software for the healthcare sector. The company's offerings include software that improves the clarity and precision of medical images, supporting diagnoses in radiology, dermatology, and ophthalmology. Claritas HealthTech serves the healthcare industry by providing tools that integrate into existing medical workflows. It is based in Singapore, Singapore.
Subtle Medical focuses on AI-powered medical imaging software in the healthcare sector. The company provides solutions that aim to reduce scan times and improve image clarity for MRI and PET imaging through deep learning algorithms. Subtle Medical's technology is intended for radiologists and imaging providers. It was founded in 2017 and is based in Menlo Park, California.
Incepto Medical provides artificial intelligence (AI) solutions for the medical imaging sector. The company operates a platform offering access to a catalog of AI applications integrated into radiology workflows. The solutions support diagnostic processes, quantify and characterize medical images, and assist in image reconstruction, covering specialties within medical imaging such as mammography, emergency radiography, and nuclear medicine. It was founded in 2018 and is based in Paris, France.
Aidoc offers clinical artificial intelligence (AI) solutions for analyzing medical imaging that aim to assist with workflow management, identifying key findings, and coordinating care teams. Its platform, aiOS, is designed to integrate with existing healthcare Information Technology (IT) systems and provides tools for care coordination and patient management. It was founded in 2016 and is based in New York, New York.
AIRS Medical serves as a healthcare artificial intelligence (AI) company that specializes in magnetic resonance Imaging (MRI) through technology. Its main offerings include AI solutions that improve the quality and efficiency of MRI scans by reducing scan times and utilizing learning for image reconstruction. AIRS Medical primarily serves the healthcare sector, with a focus on radiology and diagnostic imaging centers. It was founded in 2018 and is based in Seoul, South Korea.
Brainomix develops imaging biomarkers for precision medicine within the healthcare sector. Their products include medical software for analyzing stroke images and tools for assessing lung diseases and cancers, aimed at supporting physicians in treatment decisions. These products are utilized in the medical imaging and healthcare technology industries. It was founded in 2010 and is based in Oxford, United Kingdom.
Loading...